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ABSTRACT 
The present study focuses on in vitro antioxidant and enzyme inhibitory activity of three different solvent extracts (Methanol, Ethyl 
acetate and Hexane) of 3 different seaweeds viz: Sargassum wightii, Caulerpa racemosa, and Acanthophora spicifera. The 
preliminary phytochemical analyses of the seaweed extracts have revealed the presence of various phytochemicals. The antioxidant 
activities of the seaweed extracts have shown the scavenging effect. Among the extracts, SWEA, SWME and SWHE have exerted 
effective antioxidant activity with the IC50 values (µg/mL) of: 32.86, 130.1 and 212.8, respectively. And similar trend of α-amylase 
and α-glucosidase activity/inhibitory property by seaweeds have been recorded. Hence, the ethyl acetate extract of S. wightii was 
subjected to gas chromatography. All the seaweed extracts were characterized through HPLC and FTIR analyses. The GC-MS 
analysis of ethyl acetate extract of S. wightii showed the presence of a bioactive compound, Heptadecanoic acid that might be have 
been the reason for the recorded inhibitory activity. 
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INTRODUCTION 
Diabetes mellitus (DM) is a chronic disease, and type 2 
DM is characterized by disorder in carbohydrate, lipid 
and fat metabolism which severely affects the various 
organs of the body 
1
. DM would cause various 
complications such as renal failure, cardiovascular 
disease, blindness or other liver disease 
2
. In 2015, an 
estimated 1.6 million deaths were directly caused by 
diabetes. The recorded another 2.2 million deaths in 
2012 has been related to the high blood glucose. Almost 
half of such deaths have been attributed to high blood 
glucose that occurs before the age of 70 years. WHO 
projects that diabetes will be the seventh leading cause 
of death in 2030 
3
. Type 2 diabetes is one of the primary 
threats to human health due to its increased prevalence, 
chronic course and disabling complications 
4
. 
Hyperglycemic condition results in an uncontrolled 
production of free radicals, resulting in oxidative stress, 
which in turn leads to development and progression of 
diabetes and related complications 
5
. Many diverse 
therapeutic strategies have been adopted for the 
treatment of Type 2 diabetes. The conventional available 
therapies for diabetes include stimulation of endogenous 
insulin secretion, enhancement of the action of insulin at 
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the target tissues, oral hypoglycemic agents, such as 
biguanids and sulfonylureas and the inhibition of 
degradation of dietary starch by glycosidases such as α-
amylase and α -glucosidase. A number of anti-diabetic 
drugs including biguanides and thiazolidinedione have 
lost effectiveness against this disease, due to drug 
resistance and which leads to serious side effects, such 
as heart failure or liver disease, cardiovascular risk, 
hepatotoxicity, hypoglycemia, weight gain, lactic 
acidosis, acute pancreatitis and gastrointestinal adverse 
effects, and hence the need for searching safe 
antidiabetic medicines from natural plant sources seems 
to be promising 
6
. During the recent decades, the 
bioactive compounds extracted from bio-resources like 
microorganisms, terrestrial and marine plants were tried 
against diabetes 
7
.  
Seaweed has been traditionally consumed as a readily 
available whole food especially by coastal communities 
particularly in Asia. Seaweeds are rich in bioactive 
compounds in the form of polyphenols, carotenoids, 
vitamins, phycobilins, phycocyanins, and 
polysaccharides, among others, and many of these are 
known to possess beneficial applications in human 
health 
8
. Polyphenolic compounds are known to form 
complexes upon interaction with numerous proteins and 
those derived from seaweeds exhibit various activities 
including anti-diabetes 
9
. Some earlier researchers have 
reported that the seaweeds, Caulerpa racemosa 
10
, 
Ecklonia stolonifera 
11
, Grateloupia elliptica 
12
, 
Sargassum ringgoldianum 
13
, Ulva rigida 
14
 and 
Sargassum patens 
15
 possess potent inhibitory property 
of carbohydrate hydrolyzing enzymes. Sargassum 
wightii Greville ex J. Agardh 1848 is a brown alga 
belonging to the family, Sargassaceae and order Fucales 
and is widely distributed in tropical and temperate 
oceans and it is reported to be used as an animal food, 
food ingredient and fertilizer. A wide range of biological 
properties of this seaweed have been reported which 
includes antibacterial 
16
, antidiabetic 
17
, antioxidant 
18
, 
anti-inflammatory and antihypertensive 
19
. Acanthafora 
spicifera (M.Vahl) Børgesen 1910 is a red alga 
belonging to the family, Rhodomelaceae and order 
Ceramiales. And some earlier investigation on this alga 
underlined its antibacterial 
20
, antifungal 
21
, 
antinociceptive and anti-inflammatory properties 
22
. 
Caulerpa racemosa (Forsskål) J. Agardh 1873 is a green 
alga belonging to the family Caulerpaceae and order 
Bryopsidales. The bio-efficacy of this alga is 
antibacterial and larvicidal 
23
 and antioxidant & 
antiproliferative values 
24
.  In view of the above, the 
present study was to evaluate the in vitro enzyme 
inhibitory activity of above seaweeds against α-amylase 
and α-glucosidase. 
MATERIALS AND METHODS 
Sample collection 
Fresh samples of Sargassum wightii, Acanthafora 
spicifera and Caulerpa racemosa were collected from 
the intertidal region of Mandapam, Ramanathapuram 
District, Tamil Nadu, Southeast coast of India (9° 22' N, 
78° 52 ' E) (Figure. 1). 
 
Figure 1: a) Map showing site of seaweeds collection b) Sargassum wightii, c) Acanthafora spicifera and d) Caulerpa 
racemosa 
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Processing of seaweed samples 
The collected seaweed samples were washed with 
marine water and then transported to the laboratory in a 
plastic cover and then washed thoroughly with tap water 
followed by distilled water until the debris and 
associated biota were removed. Then they were shade-
dried for 3-weeks. Then the dried materials of all the 
seaweeds were ground using the kitchen electric 
blender. The seaweeds were identified based on the 
morphological characteristics using the standard keys 
25
 
and the identification was subsequently confirmed by Dr. 
N. Kaliaperumal, Principal Scientist (Retd.), Central 
Marine Fisheries Research Institute, Mandapam Camp, 
Ramanathapuram District (India). The reference 
specimens (PU/MBEG/V.022) have been kept in the 
Department of Biotechnology, Periyar University, 
Salem, Tamil Nadu (India). All the chemicals used in 
the study were of analytical grade with maximum purity. 
Bioactive compound extraction  
About 10 g of each powdered seaweed material was 
initially soaked into 150 mL of methanol, ethyl acetate 
and hexane for three days with mild shaking. Then the 
extract was filtered through Whatman filter paper and 
concentrated in Rotary evaporator. Further the 
concentrated methanol, ethyl acetate and hexane extracts 
of Sargassum wightii (SWME, SWEA and SWHE), 
Acanthafora spicifera (ASME, ASEA and ASHE) and 
Caulerpa racemosa (CRME, CREA and CRHE) were 
stored in refrigerator until use. 
Phytochemical screening 
The freshly prepared seaweed samples were subjected to 
preliminary phytochemical screening as per the standard 
protocol 
26
. 
Characterization of seaweed extracts 
Purity analysis by High Performance Liquid 
Chromatography (HPLC) 
The HPLC analyses of seaweed extracts were carried 
out by following the standard protocol 
27
. About 1 mg of 
each sample was dissolved in 1 mL of methanol and 20 
µL was injected. Methanol: water (50:50) was used as 
mobile phase. The experiment was performed in 
Shimadzu LC solution 20 AD, Japan and SPD 20 A, an 
instrument equipped with a UV detector (254 nm) in 
order to determine the peak purity. LCGC C18 column 
was used for isocratic resolution using the mobile phase 
at a flow rate of 1.0 mL/min. 
Fourier Transformer Infrared Spectrophotometer 
(FT-IR) 
The FTIR analysis of seaweed extracts were performed 
using FTIR spectrometer coupled with TGS (Tri-glycine 
sulphate) detector (Bruker, D8, Germany model). In 
brief, 1 mg of each dried sample was mixed with 100 
mg of potassium bromide (KBr) and then compressed to 
prepare salt-disc (3 mm dia). These discs were recorded 
in the mid-IR region 4000˗400 cm-1 at room resolution 4 
cm
-1
 
28
. 
DPPH radical scavenging assay 
DPPH (1, 1-Diphenyl-2-picryl-hydrazyl) radical 
scavenging activity of seaweed extracts were performed 
according to the earlier method 
29
. In brief, 2 mL(1 
mg/mL) of samples and standard at different 
concentrations (3.125, 6.25, 12.50, 25, 50 and 100 
µg/mL) were mixed with 1 mL of 0.1 mM DPPH in 
methanol. The mixture was instantly shaken and 
incubated for 30 min in dark condition. The absorbance 
of the samples and control was measured at 517 nm. 
Ferric Ion Reducing Power (FRAP) assay 
FRAP assay of To-HE and To-AE was performed 
according to Adedayo et al 
30
. The FRAP stock reagent 
was prepared with 300 mM/L acetate buffer (pH-3.6), 
10 mM/L TPTZ (2, 4, 6- tri [2-pyridyl]-s-triazine) and 
20 mM/L ferric chloride hexahydrate solution. The 
working solution was prepared with 30mLof acetate 
buffer, 4 mL of TPTZ solution and 4mLof ferric 
chloride hexahydrate solution. In brief, 500 µL (1 
mg/mL) of different concentration (3.125-100 µg/mL) 
of samples and standard were prepared and methanol 
was added to 2.5 mL of FRAP reagent and then 
incubated in dark for 30 min. The absorbance of the 
samples and control was measured at 593 nm. All the 
experiments were performed in triplicate. Ascorbic acid 
was used as a standard 
30
. 
Statistical analysis 
The in vitro antioxidant activities of the samples were 
calculated using the following formula: 
0 1
0
A - A
% Inhibition = ×100
A  
Where, A0 is absorbance of the control, A1 is absorbance 
of the sample. 
In vitro Antidiabetic activity 
α- amylase inhibitory activity 
The α-amylase inhibitory activity of seaweed extracts 
was evaluated according to the standard procedure of 
Matsui et al. 
31
. Two hundred micro liter of starch (0.4 
mg/mL) and 100 μL of seaweed extracts (1 mg/mL), at 
varied concentration (3.125-100 μg/mL), were dissolved 
in phosphate buffer (20 mM. NaH2PO4 and 6.7 mM. 
NaCl, pH 6.9). Consequently, 50 μL of α-amylase 
solution (1 U/mL in phosphate buffer) was added to the 
sample mixture, after which phosphate buffer was added 
to obtain a final volume of 500 μL. Then, the reaction 
mixture was incubated at room temperature for 3 min to 
facilitate the enzymatic reaction to occur. Finally, the 
reaction was terminated by adding 1mLof 0.1% 
hydrochloric acid. Subsequently, iodine reagent was 
added to the mixture. The decrease in starch 
concentration due to the activity of α-amylase was 
measured at 660 nm using a multi-well ELISA plate 
reader (Tokyo, Japan). 
α-glucosidase inhibitory activity 
The α-glucosidase inhibitory activity of seaweed 
extracts was performed as per the modified method of 
Sheliya et al. 
32
. In brief, 50 µL of seaweed extracts (1 
mg/mL) at different concentrations (3.125-100 μg/mL) 
Deepak et al                                                                                                           Journal of Drug Delivery & Therapeutics. 2018; 8(2):60-72                     
ISSN: 2250-1177                                                                               [63]                                                                              CODEN (USA): JDDTAO 
and 50 µL of 0.1 M phosphate buffer (pH 6.8) 
containing α-glucosidase solution (0.1 µL/mL) were 
incubated at 37°C for 10 min. After, 50 µL of 2.5 mM 
p-nitrophenyl-α-D-glucopyranoside (PNPG) solution 
was added in the same buffer and incubated for 20 min. 
Then, the reaction was terminated by adding 100 µL of 
0.2 M Na2CO3 and absorbance was recorded at 405 nm. 
Gas Chromatography-Mass Spectrometry (GC-MS) 
GC analysis of SWEA was performed by injecting 1µL 
of sample on a 5MS column of GC-MS model (Perkin 
Elmer, Massachusetts, USA) mobile phase: Helium. The 
qualitative and quantitative analysis of SWEA was 
carried out using a CP 3800 Saturn 2200 Gas 
Chromatography-Mass Spectrometer. The temperature 
program was 80°C to 350°C at the rate of 3°C/min 
increase. Ion temperature was 200°C and scan range was 
20-500 AMU (Atomic Mass Unit). The identification of 
components was based on comparison of their mass 
spectra with those of Wiley library 
33
. 
RESULTS 
Phytochemical screening 
The results of phytochemical analyses of all the seaweed 
extracts revealed the presence of various phyto-
constituents (Table.1). SWEA revealed the presence of 
all the tested phytochemical whereas SWME has shown 
positive result to all the tested phytochemical except 
alkaloids. Similarly ACHE has indicated that except 
tannin all the other phytochemicals were found to be 
present.
 
Table 1: Phytochemical analyses of seaweed extracts 
Phytochemical SWME SWEA SWHE ACME ACEA ACHE CRME CREA CRHE 
Flavonoids + + - + - + + + - 
Saponins + + + - + + + - + 
Tannin + + - + + - - - + 
Phenolics + + + + + + + + + 
Alkaloids - + + - - + + - + 
Steroids + + - + - + - + - 
[+] Present; [-] Absent 
 
High Performance Liquid Chromatography (HPLC) 
The HPLC analysis of seaweed extracts indicated the 
presence of various bioactive compounds as it shown 
many peaks (Fig.2). The major peaks found in the 
extracts of S. wightii with the retention time (RT) are of 
5.464 (SWME), 5.494 (SWEA) and 5.283 (SWHE), 
whereas the extracts of A. spicifera are: 2.836 (ASME), 
2.851 (ASEA) and 2.565 (ASHE). Similarly, the 
extracts of C. racemosa have shown the following 
peaks: 2.959 (CRME), 2.856 (CREA) and 2.983 
(CRHE). 
Fourier Transformer Infrared Spectrophotometer 
(FT-IR) 
The results of FTIR analysis of the three different 
solvent extracts of Sargassum wightii, Acanthafora 
spicifera and Caulerpa racemosa are shown in Figs. 3-5 
and their corresponding functional groups are depicted 
in Tables 2-4. The FTIR analysis of SWME revealed 
the presence of eight major peaks at 3408.87, 2925.22, 
1736.31, 1651.14, 1541.00, 1169.89, 1037.00 and 
721.58 cm
-1
, and the SWEA displayed nine peaks at 
3423.68, 2925.57, 2854.2, 1569.89, 1424.31, 1299.38, 
1015.26, 879.35 and 650.84 cm
-1
. And the SWHE have 
shown ten peaks at 3192.54, 2918.12, 2849.72, 2081.86, 
1632.30, 1578.03, 1541.39, 1419.37, 1249.31 and 
1077.04 cm
-1
. The methanol extract of A. spicifera has 
revealed the presence of seven peaks at 3243.08, 
2917.53, 2849.94, 2077.74, 1636.61, 1384.52 and 
1045.60 cm
-1
, and the ASEA revealed the presence of 
nine major peaks at 3406.02, 2919.57, 2852.00, 
1725.12, 1561.34, 1420.80, 1272.20, 1078.49 and 
718.43 cm
-1
.And the ASHE have also displayed the 
presence of nine major peaks at 3408.97, 2922.06, 
2851.41, 1651.52, 1457.03, 1229.06, 1037.56, 873.97 
and 464.15 cm
-1
.  
The FTIR analysis of CRME revealed the following 
peak vibrations at 3297.52, 2954.59, 2856.92, 2398.64, 
1694.29, 1579.39, 1443.58, 1323.34 and 1098.58 cm
-1
 
and the CREA has shown the functional groups of 
3383.98, 2920.83, 2852.38, 1687.31, 1563.13, 1418.65, 
1264.60, 1057.23 and 731.36 cm
-1
. Similarly, the CRHE 
has also revealed the 9-peak vibrations at 3447.72, 
2922.37, 2852.05, 1765.32, 1636.57, 1541.45, 1465.34, 
1242.31 and 1039.17 cm
-1
. 
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Figure 2:  HPLC analyses of seaweed extracts of a) SWME, b) SWEA, c) SWHE, d) ASME, e) ASEA, f) ASHE, g) CRME, h) CREA and i) CRHE.
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Figure 3: FTIR spectrum analyses of Sargassum wightii      Figure 4: FTIR spectrum analyses of Acanthafora spicifera 
 
Table 2: Functional group analyses of various solvent extracts of S. wightii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample name Vibration Stretch Functional Group 
 
 
 
SWME 
3408.87 CH Alkanes 
2925.22 -CH2- Alkanes 
1736.31 C=O Esters 
1651.14 C=C Alkanes 
1541.00 NH Amines 
1169.89 C-N Amines 
1037.00 S=O Miscellaneous 
721.58 Bending mode Alkanes 
 
SWEA 
 
3423.68 CH Alkanes 
2925.57 -CH2- Alkanes 
2854.2 -CH2- Alkanes 
1569.89 NH2 Amines 
1424.31 Ar C-C  Aromatics 
1299.38 C-F Alkyl halides 
1015.26 P-OR Miscellaneous 
879.35 C-H Aromatics 
650.84 C-Br Alkyl halides 
 
 
 
 
SWHE 
3192.54 Dimer OH Carboxylic acids 
2918.12 C=H Alkanes 
2849.72 C=O Carboxylic acids 
2081.86 N=C in R-N=C=S Miscellaneous 
1632.30 C=O Amides 
1578.03 C-O Carboxylic acids 
1541.39 NH Amides 
1419.37 Ar C-C Aromatics 
1249.31 C-Br Alkyl halides 
1077.04 C-O Ethers 
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Table 3: Functional group analyses of various solvent extracts of A. spicifera 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: Functional group analyses of various solvent extracts of C. racemosa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Name Vibration Stretch Functional Group 
 
 
ASME 
3243.08 dimer OH Carboxylic acids 
2917.53 CH Alkanes 
2849.94 -CH2 Alkanes 
2077.74 N=C in R-N=C=S Miscellaneous 
1636.61 C=N Miscellaneous 
1384.52 S=O sulfate ester Miscellaneous 
1045.60 C-N Amines 
 
 
 
ASEA 
3406.02 CH  Alkanes 
2919.57 CH Alkanes 
2852.00 CH Alkanes 
1725.12 C=O Esters 
1561.34 C=C Alkenes 
1420.80 Ar C-C  Aromatics 
1272.20 C-F Alkylhalides 
1078.49 C-N Amines 
718.43 S-OR esters Miscellaneous 
 
 
 
 
ASHE 
3408.97 CH Alkanes 
2922.06 dimer OH Carboxylic acids 
2851.41 -CH2- Alkanes 
1651.52 C=O Amides 
1457.03 Ar C-C Aromatics 
1229.06 C-N Amines 
1037.56 S=O  Miscellaneous 
873.97 S-OR esters Miscellaneous 
464.15 CBr- Alkyhalides 
Sample Name Vibration Stretch Functional Group 
 
 
 
 
CRME 
3297.52 dimer OH Carboxylic acids 
2954.59 CH Alkanes 
2856.92 CH Alkanes 
2398.64 P-H Miscellaneous 
1694.29 dimer C=O Carboxylic acids 
1579.39 C-O Carboxylic acids 
1443.58 S=O Miscellaneous 
1323.34 C-F Alkylhalides 
1098.58 dimer C=O Carboxylic acids 
 
 
 
 
CREA 
3383.98 dimer OH Carboxylic acids 
2920.83 CH Alkanes 
2852.38 CH Alkanes 
1687.31 dimer C=O Carboxylic acids 
1563.13 N=O nitroso Miscellaneous 
1418.65 S=O sulfate ester Miscellaneous 
1264.60 dimer C=O Carboxylic acids 
1057.23 S=O sulfoxide Miscellaneous 
731.36 S-OR esters Miscellaneous 
 
 
 
 
CRHE 
3447.72 CH Alkanes 
2922.37 dimer OH Carboxylic acids 
2852.05 CH Alkanes 
1765.32 Monomer C=O Carboxylic acids 
1636.57 C=O Amides 
1541.45 NH Amides 
 1465.34 Ar C-C  Aromatics 
 1242.31 C-F Alkylhalides 
 1039.17 P-H Miscellaneous 
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Figure 5: FTIR spectrum analyses of Caulerpa racemosa-extract 
DPPH radical scavenging assay 
The DPPH scavenging property of the seaweed extracts 
were compared with the positive control, ascorbic acid 
(Fig. 6). Among the different concentration of 
samples/control used in this study, 100 µg/mL of S. 
wightii extracts resulted in the highest scavenging effect 
of 41.40% (SWME), 68.01% (SWEA), 36.06% (SWHE) 
and 72.49% (ascorbic acid). The IC50 values (µg/mL) of 
SWME, SWEA, SWHE and ascorbic acid were: 
130.1±1.44, 32.86±1.96, 212.8±0.77 and 30.32±1.92, 
respectively.
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Figure 6: DPPH scavenging activities of seaweed extracts. 
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Ferric Ion Reducing Power (FRAP) assay 
Among the various concentration of seaweed extracts, 
100 µg/mL of S. wightii extract exerted the highest 
scavenging effect of 36.95 % (SWME), 68.09% 
(SWEA), 32.94% (SWHE) and 75.03% (ascorbic acid) 
(Fig.7). The IC50 values (µg/mL) of SWME, SWEA, 
SWHE and ascorbic acid were: 306.5±0.99, 32.56±1.39, 
226.6±0.37 and 27.24±2.01, respectively. 
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Figure 7: FRAP scavenging activities of seaweed extracts. 
 
In vitro Antidiabetic activity 
α- amylase inhibitory activity 
The inhibitory percentage of α- amylase by the different 
seaweed extracts are shown in Fig. 8. The three different 
extracts of S. wightii have showed the highest inhibitory 
percentage of α- amylase when compared to the seaweed 
extracts of A. spicifera and C. racemosa with the IC50 
values (µg/mL) of SWME, SWEA and SWHE being: 
41.8 ±0.64, 13.15 ±1.17 and 122.5 ±1.95 respectively. 
The positive control (acarbose) has shown the potent α- 
amylase inhibitory activity with the IC50 value (µg/mL) 
of 8.946 ±1.21. 
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Figure 8: α-amylase inhibitory activity of seaweed extracts. 
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Figure 9: α-glucosidase inhibitory activity of seaweed extracts 
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α-glucosidase inhibitory activity 
The inhibition of α-glucosidase by the different seaweed 
extracts are depicted in Fig. 9. The maximum inhibition 
of α-glucosidase was exerted by the extracts of S. 
wightii with the IC50 values (µg/mL) of SWME, SWEA 
and SWHE being: 60.12±0.92, 20.44±0.36 and 
71.20±0.12 respectively. And the effective inhibitory 
property of α-glucosidase was revealed by the positive 
control (acarbose) with the IC50 value (µg/mL) of 
20.10±0.53. 
Gas Chromatography-Mass Spectrometry (GC-MS) 
The GC-MS analysis of SWEA indicated the presence 
of 8 compounds (Fig. 10 and Table.5). The recorded 
phyco-constituents of the ethyl acetate extract of S. 
wightii are: Phloretin (MW: 273,  MF:C15H13O5, 
RT:2.96), Heptadecanoic acid (MW: 270, MF: C17H34O2, 
RT:19.95), Oleic acid (MW: 282, MF: C18H34O2, 
RT:21.00), 5-p-coumaroylquinic acid (MW: 337, MF: 
C16H17O8, RT:24.09), Phloretinrhamnosyl(1→6) 
glucoside (MW: 581, MF: C27H33O14, RT:26.41), 
Quercetin-3-O- arabinpyranoside (MW: 433, MF: 
C20H17O11, RT:26.80), Caffeic acid hexoside (MW: 341, 
MF: C15H17O9, RT:28.47) and Squalene (MW: 410, MF: 
C30H50, RT:29.97). The percentage of peak area and 
details of the biological properties of each compounds 
are represented in Table 5. 
 
 
Figure 10: GC-MS analysis of SWEA 
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Table 5: Chemical constituents of SWEA analyzed by Gas Chromatography-Mass Spectrometry 
RT 
(min) 
S. 
No 
Compound Name MW Molecular 
formula 
Peak 
area 
Biological Properties Reference 
2.96 1 Phloretin 273 C15H13O5 1.52 Antioxidant Nithiya and 
Udayakumar, 2015 
19.95 2 Heptadecanoic acid 270 C17H34O2 66.38 Antioxidant and anti-
proliferative 
Elagbar et al., 2016 
21.00 3 Oleic acid 282 C18H34O2 1.50 Antioxidant, cell 
proliferation and prevents 
the Pro-apoptotic effect 
Wei et al., 2016; 
Mancini et al., 2015 
24.09 4 5-p-coumaroylquinic acid  337 C16H17O8 4.37 Antioxidant Karamać et al., 
2012 
26.41 5 Phloretinrhamnosyl(1→6) 
glucoside 
581 C27H33O14 6.45 No activity found ---- 
26.80 6 Quercetin-3-O- 
arabinpyranoside 
 
433 C20H17O11 8.57 Antibacterial, anti-
inflammatory, 
antioxidant, and antiviral 
David et al., 2016 
28.47 7 Caffeic acid hexoside 341 C15H17O9  Antioxidant and 
cytoprotection 
Gaglione et al., 
2013 
29.97 8 Squalene 410 C30H50 11.10 Antioxidant, anticancer, 
anti-infectant 
Kim and Karadeniz, 
2012 
 
 
DISCUSSION 
Marine algae are known to be an important source for 
bioactive compounds of important pharmaceutical 
metabolites and biomedical potential. In particular, the 
brown algae have a variety of biological compounds 
such as pigments, fucoidans, phycocolloids, and 
phlorotannins. Among them, phlorotannins have been 
extensively studied for their potential health benefits and 
they have shown promising antidiabetic effects 
34
. There 
are many reports that suggested that seaweeds contain 
biologically active compounds than the plants found in 
the terrestrial area 
35
. Seaweeds are a natural source of 
bioactive molecules with a broad range of biological 
activities, such as antibiotics, antivirals, anti-tumorals, 
antioxidants and anti-inflammatories. The 
phytochemical constituents such as flavonoids, tannins, 
phenolics, sterols and terpenoids are secondary 
metabolites of seaweeds that serve as defense 
mechanism against different infectious diseases 
36
. In the 
present study the phytochemical analysis of three 
different solvent (methanol, ethyl acetate and hexane) 
extracts of seaweeds, S. wightii, A. spicifera and C. 
racemosa revealed the presence of various 
phytochemicals at different concentrations of solvent 
polarity. The earlier report of Baleta et al. 
36
 have 
showed the phytochemicals present in the brown algae, 
S. oligocystum and S. crassifolium were found to vary 
according to the type of  solvents used. The phyto-
constituents such as, phenols and flavonoids were 
reported for enhancing the scavenging of free radicals, 
as we have found in the present study 
37
. The biological 
activity of any bio-organic compound may be influenced 
by its functional groups. Hence, the FTIR analysis of the 
extract would shed light on the physicochemical 
properties of a compound. Presently, the FTIR analysis 
of seaweed extracts have shown the presence of various 
functional groups viz; carboxylic acid, alkanes, alkynes, 
aromatics and alkyl halides which are similar to the 
earlier study of Fernando et al. 
38
.  
Natural antioxidants are not limited to terrestrial sources 
and reports have revealed seaweeds to be rich sources of 
natural antioxidant compounds. The presence of 
antioxidant substances in seaweeds is considered to be 
an endogenous defense mechanism as a protection 
against oxidative stress due to extreme level of 
environmental conditions 
39
. During the earlier study it 
was found reported that the antioxidant activity of 
brown seaweed extracts correlated with their polyphenol 
content and this might have been the cause of the 
presently recorded inhibitory effects 
40
. Devi et al. 
41
 
reported the maximum inhibition of DPPH scavenging 
by red alga, Gelidiella acerosa with the IC50 value 
(µg/mL) of:  72.5 ± 2.78. Indu and Seenivasan, 
42
 have 
reported that maximum scavenging effect of DPPH was 
shown by the ethanol extract of S. wightii (79.1±0.23 %) 
and also its acetone extract (78.8±0.18 %) that are 
comparable to the present findings. The methanolic 
extracts of the brown seaweeds were able to reduce Fe
3+
 
to Fe
2+
 in a concentration-dependent manner as a 
function of reducing power as reported earlier 
43
. 
The most common therapeutic approach to treat diabetes 
is reduction of postprandial hyperglycemia. This can be 
achieved by inhibition of enzymes involved in the 
release of glucose from foods and this approach is used 
in the management of type 2-diabetes, with the main 
target being α-amylase and α-glucosidase. α -amylase is 
an enzyme responsible for the breakdown of complex 
carbohydrate like starch to more simple sugars like 
glucose. Thus, the inhibition of this enzyme can delay 
the carbohydrate digestion and reduce the rate of 
glucose absorption. Natural α-amylase inhibitor offers 
an attractive therapeutic approach in the treatment of 
postprandial hyperglycemia, through decreased glucose 
release from starch. Marine seaweeds that can reduce 
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postprandial hyperglycemia by inhibiting enzymes such 
as α -amylase and α -glucosidase are found to be an 
effective strategy for the management of diabetes 
44
. In 
the present study, ethyl acetate extract of S. wightii have 
shown the maximum inhibition of α-amylase (13.15 
±1.17). Similarly, Payghami et al. 
45
 have reported that 
the brown alga, Sargassum glaucescens exerted 
maximum inhibitory activity on α-amylase with has the 
minimum IC50 value of  8.9 ± 2.4 mg/mL. Presently, the 
GC-MS analysis of SWEA revealed the presence of 8 
active compounds viz; Phloretin, Heptadecanoic acid, 
Oleic acid, 5-p-coumaroylquinic acid, 
Phloretinrhamnosyl(1→6) glucoside, Quercetin-3-O- 
arabinpyranoside, Caffeic acid hexoside and Squalene. 
Among them, Phloretin was found to have antioxidant 
activity as reported earlier 
46
. The previous research on 
GC-MS analysis of Grateloupia elliptica revealed the 
presence of squalene that has been reported to have 
antioxidant, anticancer and anti-infectant effects. The 
presently isolated bioactive compound, Heptadecanoic 
acid of SWEA, has been known to have both antioxidant 
and anti-proloferative properties 
47
. And the presently 
recorded enzyme inhibitory property of S. wightii could 
be due to its bioactive compound, Heptadecanoic acid. 
CONCLUSION 
The present study revealed that the ethyl acetate extract 
of S. wightii (SWEA) was more effective than the other 
seaweed extracts due to the presence of Heptadecanoic 
acid. In addition, the SWEA has shown maximum 
inhibition percentage with minimal inhibitory 
concentration (IC50) during the antioxidant and enzyme 
inhibitory studies. Therefore, the findings of the present 
study could form a basis for further studies towards the 
development of new pharmaceutical drug formulation 
for the treatment of Diabetes mellitus.    
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